The continous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: Results of a phase II study

Robert Provenzano, A. Besarab, I. C. Macdougall, D. H. Ellison, A. P. Maxwell, W. Sulowicz, M. Klinger, B. Rutkowski, R. Correa-Rotter, F. C. Dougherty, P. Barre, A. Levin, A. McMahon, S. W. Tobe, A. Valdes, S. Fishbane, J. Lewis, M. Leiserowitz, R. Mehta, S. Vicks

Research output: Contribution to journal › Article › peer-review

70 Scopus citations

Fingerprint

Dive into the research topics of 'The continous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: Results of a phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences